627 related articles for article (PubMed ID: 29925252)
1. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
2. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.
Zhang YG; Wu S; Yi J; Xia Y; Jin D; Zhou J; Sun J
Clin Ther; 2017 Feb; 39(2):322-336. PubMed ID: 28129947
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
[TBL] [Abstract][Full Text] [Related]
4. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in ALS: possible role in pathogenesis?
McCombe PA; Henderson RD; Lee A; Lee JD; Woodruff TM; Restuadi R; McRae A; Wray NR; Ngo S; Steyn FJ
Expert Rev Neurother; 2019 Sep; 19(9):785-805. PubMed ID: 31122082
[No Abstract] [Full Text] [Related]
6. The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review.
Erber AC; Cetin H; Berry D; Schernhammer ES
Int J Neurosci; 2020 Jul; 130(7):727-735. PubMed ID: 31870202
[No Abstract] [Full Text] [Related]
7. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
8. Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies.
Mazzini L; Mogna L; De Marchi F; Amoruso A; Pane M; Aloisio I; Cionci NB; Gaggìa F; Lucenti A; Bersano E; Cantello R; Di Gioia D; Mogna G
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S68-S70. PubMed ID: 29782468
[TBL] [Abstract][Full Text] [Related]
9. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.
Martin S; Battistini C; Sun J
Front Cell Infect Microbiol; 2022; 12():839526. PubMed ID: 35360111
[TBL] [Abstract][Full Text] [Related]
10. Gut inflammation and dysbiosis in human motor neuron disease.
Rowin J; Xia Y; Jung B; Sun J
Physiol Rep; 2017 Sep; 5(18):. PubMed ID: 28947596
[TBL] [Abstract][Full Text] [Related]
11. Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS.
Lee A; Henderson R; Aylward J; McCombe P
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339149
[TBL] [Abstract][Full Text] [Related]
12. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model.
Wu S; Yi J; Zhang YG; Zhou J; Sun J
Physiol Rep; 2015 Apr; 3(4):. PubMed ID: 25847918
[TBL] [Abstract][Full Text] [Related]
13. The fecal microbiome of ALS patients.
Brenner D; Hiergeist A; Adis C; Mayer B; Gessner A; Ludolph AC; Weishaupt JH
Neurobiol Aging; 2018 Jan; 61():132-137. PubMed ID: 29065369
[TBL] [Abstract][Full Text] [Related]
14. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence.
Sun J; Huang T; Debelius JW; Fang F
J Intern Med; 2021 Oct; 290(4):758-788. PubMed ID: 34080741
[TBL] [Abstract][Full Text] [Related]
16. The human gut microbiota in people with amyotrophic lateral sclerosis.
Nicholson K; Bjornevik K; Abu-Ali G; Chan J; Cortese M; Dedi B; Jeon M; Xavier R; Huttenhower C; Ascherio A; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2021 May; 22(3-4):186-194. PubMed ID: 33135936
[TBL] [Abstract][Full Text] [Related]
17. Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Blacher E; Bashiardes S; Shapiro H; Rothschild D; Mor U; Dori-Bachash M; Kleimeyer C; Moresi C; Harnik Y; Zur M; Zabari M; Brik RB; Kviatcovsky D; Zmora N; Cohen Y; Bar N; Levi I; Amar N; Mehlman T; Brandis A; Biton I; Kuperman Y; Tsoory M; Alfahel L; Harmelin A; Schwartz M; Israelson A; Arike L; Johansson MEV; Hansson GC; Gotkine M; Segal E; Elinav E
Nature; 2019 Aug; 572(7770):474-480. PubMed ID: 31330533
[TBL] [Abstract][Full Text] [Related]
18. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.
Gotkine M; Kviatcovsky D; Elinav E
Gut Microbes; 2020 Nov; 11(6):1833-1841. PubMed ID: 32501768
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
